Japanese drugmaker Eisai Co Ltd and its U.S. partner Biogen Inc said on Monday that the U.S. Food and Drug Administration granted priority review for traditional approval of their Alzheimer's treatment Lecanemab.
said on Monday that the U.S. Food and Drug Administration granted priority review for traditional approval of their Alzheimer's treatment Lecanemab.
The FDA accepted Eisai's supplemental Biologics License Application for the drug, supporting transition from the accelerated approval granted in January, the drugmaker said in a statement.
México Últimas Noticias, México Titulares
Similar News:También puedes leer noticias similares a ésta que hemos recopilado de otras fuentes de noticias.
How to Write a Thorough Grant Funding Proposal for a Small Business | HackerNoonRegardless of the small business, numerous grants of all sizes are up for grabs if you can persuade gifters through a well-written proposal. Find out how here! - businessdevelopment businessoperations
Leer más »
Hugh Grant reveals ‘tantrums’ on set of new movie: ‘I did a Christian Bale’“I lost my temper with a woman in my eyeline on day one. I assumed she was some executive from the studio who should have known better,” Grant explained.
Leer más »
Stephen Amell Honors Team Flash, Shares Grant Gustin Flashback ImageWith TheCW's TheFlash wrapping up filming for the last time, Arrow star StephenAmell took to social media to congratulate TeamFlash. / Arrowverse DCU GrantGustin CandicePatton Batwoman JaviciaLeslie
Leer más »
Florida lawmakers urge President Biden to grant Novak Djokovic waiver to play in US despite vaccine statusFlorida Senators Rick Scott and Sen. Marco Rubio sent a letter to the president on Friday urging him to grant Novak Djokovic a wavier to enter the U.S. despite not being vaccinated.
Leer más »
Jon Jones kisses fiancée Jessie at UFC 285, 18 months after domestic violence incidentThe longtime couple’s relationship appeared to be over last year when Jones said that Moses left him following a domestic violence incident five months prior.
Leer más »